Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology ...

Reports

5

Domains carrying it

5

First reported

25 August 2026

Latest report

27 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 25 August 2026Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology ...morningstar.com
2. 26 August 2026FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patientsreuters.com
3. 27 August 2026What Does Abbott Laboratories (ABT) FDA Clearance Mean For Its Diabetes Device Push?finance.yahoo.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA clears Roche, Lilly Alzheimer's blood tests; Regenxbio gene therapy trial halted by FDA again4 reports · 4 domains · 28 August 2026
• From Voluntary to Mandatory: FDA's Proposed GRAS Rule8 reports · 7 domains · 19 August 2026
• GRAIL Bets Its Galleri Panel Will Set The FDA Bar For Future MCEDs6 reports · 6 domains · 12 August 2026
• FDA clears new blood-based biomarker test that targets tau3 reports · 3 domains · 3 September 2026

◆ Share

◆ Evidence

5 reports · 5 domains

• What Does Abbott Laboratories (ABT) FDA Clearance Mean For Its Diabetes Device Push?finance.yahoo.com · 27 August 2026
• FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patientsreuters.com · 26 August 2026
• Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology ...prnewswire.com · 25 August 2026
• Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology ...abbott.mediaroom.com · 25 August 2026
• Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology ...morningstar.com · 25 August 2026